Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction
2011

Metabolomic Analysis of Pelizaeus-Merzbacher Disease

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Wood Paul L, Smith Tara, Pelzer Lindsay, Goodenowe Dayan B

Primary Institution: Phenomenome Discoveries Inc

Hypothesis

What are the lipid changes and metabolic consequences in cellular models of Pelizaeus-Merzbacher disease?

Conclusion

The study found significant decreases in plasmalogens and increased levels of myo-inositol in cells affected by Pelizaeus-Merzbacher disease.

Supporting Evidence

  • Ethanolamine plasmalogens were significantly decreased in PMD fibroblasts and lymphocytes.
  • Cellular levels of myo-inositol were dramatically increased in PMD cells.
  • Uptake studies showed increased rates of myo-inositol uptake by PMD lymphocytes.

Takeaway

This study looked at cells from a disease called Pelizaeus-Merzbacher disease and found that they had less of a certain fat and more of a sugar called myo-inositol, which might be causing problems in the cells.

Methodology

Targeted lipidomic and metabolomic analyses were performed on PMD fibroblasts, lymphocytes, and 158JP oligodendrocytes.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1476-511X-10-102

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication